Match each clinical presentation with the most appropriate first-line targeted or empiric antimicrobial therapy.
- A 24-year-old camper in North Carolina develops fever, severe myalgias, headache, and a petechial rash originating on the wrists and ankles.Oral doxycycline
- A 32-year-old intravenous drug user presents with high fever, a new tricuspid regurgitation murmur, and scattered cavitary lung lesions on chest imaging.Intravenous vancomycin
- A 19-year-old college dormitory resident presents with sudden fever, nuchal rigidity, and a rapidly spreading purpuric rash on the lower extremities.Intravenous ceftriaxone
- A 55-year-old farmer from Ohio presents with chronic cough, low-grade fever, and well-circumscribed verrucous skin lesions; microscopy shows broad-based budding yeast.Oral itraconazole
Answer
The camper with wrist/ankle rash requires oral doxycycline (RMSF); the IV drug user with right-sided endocarditis requires intravenous vancomycin (MRSA); the college student with purpuric meningitis requires intravenous ceftriaxone (Meningococcus); and the farmer with broad-based budding yeast requires oral itraconazole (Blastomycosis).
Each pathogen or clinical syndrome has a highly specific first-line antimicrobial agent guided by local epidemiology, resistance patterns, and pharmacokinetics (such as CNS penetration for meningitis or intracellular activity for rickettsial disease).
Step-by-Step Solution
Key Concept
Selection of optimal empiric or targeted antimicrobial therapy based on clinical presentation, epidemiologic risk factors, and microbiological clues.